Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02991898 · OUTCOME

Number of Participant With Detectable Treg Cells at d14

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies · Source last updated 2020-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
14 days

What was measured

The proportion of patients with detectable Treg cells at day 14 post infusion

Analysis population: Samples were not analyzed, and so data not available for reporting.

Groups in this outcome

Treg Infusion

The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treg Infusion0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
The proportion of patients with detectable Treg cells at day 14 post infusion
groups
  1. description
    The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion
    id
    OG000
    title
    Treg Infusion
population Description
Samples were not analyzed, and so data not available for reporting.
reporting Status
POSTED
time Frame
14 days
title
Number of Participant With Detectable Treg Cells at d14
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice